Project Details
| Acronym | IMU.201.101 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/08/20 → 30/06/25 |
An open label, multi-centre, dose escalation/expansion, phase1 study of IMU-201 (PD1-Vazz) a B-cell immunotherapy in adults with non-small cell lung cancer
- Park, John (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research